![Irinotecan HCl <br>40 mg / 2 mL Intravenous Injection <br>Single Dose Vial 2 mL <br> Teva 00703443211 Irinotecan HCl <br>40 mg / 2 mL Intravenous Injection <br>Single Dose Vial 2 mL <br> Teva 00703443211](https://s.turbifycdn.com/aah/yhst-12533177228474/irinotecan-hcl-40-mg-2-ml-intravenous-injection-single-dose-vial-2-ml-teva-00703443211-56.gif)
Irinotecan HCl <br>40 mg / 2 mL Intravenous Injection <br>Single Dose Vial 2 mL <br> Teva 00703443211
![Иринотекан-ТЕВА (Irinotecan-TEVA) конц. д/п инф. р-ра 100 мг фл. 5 мл :: Вартість, Інструкція, Купити - Аптека 0303 Иринотекан-ТЕВА (Irinotecan-TEVA) конц. д/п инф. р-ра 100 мг фл. 5 мл :: Вартість, Інструкція, Купити - Аптека 0303](https://www.apteka0303.com.ua/goods/xl999474.jpg)
Иринотекан-ТЕВА (Irinotecan-TEVA) конц. д/п инф. р-ра 100 мг фл. 5 мл :: Вартість, Інструкція, Купити - Аптека 0303
![Acquired irinotecan resistance is accompanied by stable modifications of cell cycle dynamics independent of MSI status Acquired irinotecan resistance is accompanied by stable modifications of cell cycle dynamics independent of MSI status](https://www.spandidos-publications.com/article_images/ijo/42/5/IJO-42-05-1644-g03.jpg)
Acquired irinotecan resistance is accompanied by stable modifications of cell cycle dynamics independent of MSI status
![Irinotecan Hydrochloride API Manufacturers | Suppliers | Drug Master Files (DMF) | CEP | Pharmacompass.com Irinotecan Hydrochloride API Manufacturers | Suppliers | Drug Master Files (DMF) | CEP | Pharmacompass.com](https://www.pharmacompass.com/image/ads250/avra-irinotecan-hydrochloride-rmgif-53796.gif)
Irinotecan Hydrochloride API Manufacturers | Suppliers | Drug Master Files (DMF) | CEP | Pharmacompass.com
![Acquired irinotecan resistance is accompanied by stable modifications of cell cycle dynamics independent of MSI status Acquired irinotecan resistance is accompanied by stable modifications of cell cycle dynamics independent of MSI status](https://www.spandidos-publications.com/article_images/ijo/42/5/IJO-42-05-1644-g01.jpg)
Acquired irinotecan resistance is accompanied by stable modifications of cell cycle dynamics independent of MSI status
![WO2017003120A1 - Oral solid formulation containing irinotecan and method of preparing the same - Google Patents WO2017003120A1 - Oral solid formulation containing irinotecan and method of preparing the same - Google Patents](https://patentimages.storage.googleapis.com/61/36/30/75d3cfd1907a11/PCTKR2016006513-appb-I000001.png)
WO2017003120A1 - Oral solid formulation containing irinotecan and method of preparing the same - Google Patents
![Иринотекан-Тева — инструкция по применению, дозы, побочные действия, описание препарата: концентрат для приготовления раствора для инфузий, 20 мг/мл Иринотекан-Тева — инструкция по применению, дозы, побочные действия, описание препарата: концентрат для приготовления раствора для инфузий, 20 мг/мл](https://app.rlsnet.ru/api/storage/packing/gif/4976_a.gif)
Иринотекан-Тева — инструкция по применению, дозы, побочные действия, описание препарата: концентрат для приготовления раствора для инфузий, 20 мг/мл
![Ipsen and Servier Announce Initial Phase 1/2 Clinical Data Evaluating Liposomal Irinotecan (ONIVYDE®) as an Investigational First-line Treatment for Metastatic Pancreatic Cancer at ESMO 21st World Congress on Gastrointestinal Cancer – Intelligence Ipsen and Servier Announce Initial Phase 1/2 Clinical Data Evaluating Liposomal Irinotecan (ONIVYDE®) as an Investigational First-line Treatment for Metastatic Pancreatic Cancer at ESMO 21st World Congress on Gastrointestinal Cancer – Intelligence](https://intelligencepharma.files.wordpress.com/2019/07/2l-image-99.jpg)
Ipsen and Servier Announce Initial Phase 1/2 Clinical Data Evaluating Liposomal Irinotecan (ONIVYDE®) as an Investigational First-line Treatment for Metastatic Pancreatic Cancer at ESMO 21st World Congress on Gastrointestinal Cancer – Intelligence
![Irinotecan-mediated diarrhea is mainly correlated with intestinal exposure to SN-38: Critical role of gut Ugt - ScienceDirect Irinotecan-mediated diarrhea is mainly correlated with intestinal exposure to SN-38: Critical role of gut Ugt - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0041008X20301563-gr1.jpg)